• Skip to primary navigation
  • Skip to content

Persist Communications

Automated Lead Communication Software and Services

  • Home
  • Persist Software
    • Persist Software Affiliate Program
  • Lead Conversion
  • Affiliate Program
  • Contact
  • News
  • (866) 473-7747
Home » Mass Torts » Alabama Generic Drug Lawsuits Ruling

Alabama Generic Drug Lawsuits Ruling

February 27, 2013 By: Persist

Patients who have been injured by generic versions of so many popular medications such as Accutane, Fosamax, Lipitor, Darvocet and others can now pursue generic drug lawsuits against brand name drug makers following an Alabama Supreme Court ruling Friday.

According to the New York Times on Friday, January 11, 2013, the Alabama Supreme Court ruled that people injured by generic drugs could now sue the name brand company for failing to warn about a drug’s risks, even though they took a generic version of the product, which the company did not even manufacture. The U.S. Supreme Court had previously barred most lawsuits against generic drug manufacturers since its decision in Pliva v. Mensing.

Although the decision applies only to Alabama, it is sure to be closely read by lawyers around the country with similar pending cases, whose clients have been barred from suing generic companies. This will hopefully pave the way for victims of generic drug injuries across the nation to receive compensation for their pain and suffering.

Patients who claim that Wyeth failed to properly warn them of Reglan’s risks have filed hundreds of lawsuits.

The Alabama case of Danny Weeks claimed that he developed tardive dyskinesia (TD), a movement disorder, after taking metoclopramide (MCP), the generic version of Reglan, to treat his gastroesophageal reflux (GERD). Mr. Weeks sued Actavis and Teva, the generic companies that manufactured the drugs, as well as Wyeth (purchased from Pfizer), who developed the drug, for failing to adequately warn about Reglan’s risks.

Read the full story >>

Share

Related posts:

Yaz and Yasmin Birth Control PillsIt is Not Too Late to File Suit Against Makers of Yaz and Yasmin Mirena IUD LawsuitsBayer’s Mirena IUD Lawsuits Continue to Pile Up Transvaginal MeshJury Awards $3.35M in Transvaginal Mesh (TVM) Case Granuflo and naturalyteGranuFlo & NaturaLyte Linked to Death

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Home
  • Request A Demo or Free Consultation
  • Persist Software
  • Lead Conversion
  • News
  • Persist Software Affiliate Program
  • Contact Us

Persist Communications, Inc. is a business organization that provides marketing, IT, software and call center services to law firms and other organizations. Persist is a follow up system that improves efficiency and productivity of contact. Persist Communications, Inc. does NOT perform cold calls. All leads generated and contacted by Persist Communications, Inc. are obtained through internet, social media or mass media.



PersistTM Communications | All Rights Reserved | (866) 473-7747